A new trading day began on Monday, with Applied Dna Sciences Inc (NASDAQ: APDN) stock price down -20.34% from the previous day of trading, before settling in for the closing price of $1.15. APDN’s price has ranged from $1.02 to $397.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 60.75%. Meanwhile, its annual earnings per share averaged 73.63%. With a float of $6.05 million, this company’s outstanding shares have now reached $6.50 million.
Let’s determine the extent of company efficiency that accounts for 48 employees. In terms of profitability, gross margin is 34.35%, operating margin of -353.23%, and the pretax margin is -230.85%.
Applied Dna Sciences Inc (APDN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Applied Dna Sciences Inc is 6.82%, while institutional ownership is 6.72%.
Applied Dna Sciences Inc (APDN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.63% per share during the next fiscal year.
Applied Dna Sciences Inc (NASDAQ: APDN) Trading Performance Indicators
Here are Applied Dna Sciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -285.87, a number that is poised to hit -3.00 in the next quarter and is forecasted to reach -5.50 in one year’s time.
Technical Analysis of Applied Dna Sciences Inc (APDN)
Looking closely at Applied Dna Sciences Inc (NASDAQ: APDN), its last 5-days average volume was 1.64 million, which is a jump from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 6.88%. Additionally, its Average True Range was 0.41.
During the past 100 days, Applied Dna Sciences Inc’s (APDN) raw stochastic average was set at 0.18%, which indicates a significant decrease from 1.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.45% in the past 14 days, which was lower than the 192.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.9027, while its 200-day Moving Average is $21.1164. However, in the short run, Applied Dna Sciences Inc’s stock first resistance to watch stands at $0.9711. Second resistance stands at $1.0260. The third major resistance level sits at $1.0641. If the price goes on to break the first support level at $0.8781, it is likely to go to the next support level at $0.8400. Should the price break the second support level, the third support level stands at $0.7851.
Applied Dna Sciences Inc (NASDAQ: APDN) Key Stats
With a market capitalization of 5.95 million, the company has a total of 1,104K Shares Outstanding. Currently, annual sales are 3,430 K while annual income is -6,990 K. The company’s previous quarter sales were 1,200 K while its latest quarter income was -2,640 K.
